Type to search

Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron | Pharmtech Focus
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC | Pharmtech Focus
10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region | Pharmtech Focus